{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:35:00Z","timestamp":1794270900260,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immune escape due to immunosuppressive microenvironments, such as those associated with regulatory T (Treg) cells is highly associated with initial occurrence and development of solid tumors or hematologic malignancies. Here, we employed high-throughput transcriptome screening to demonstrate immunosuppression-associated increases in the long noncoding (lnc) RNA lnc-insulin receptor precursor (INSR), which was corrected with INSR expression in CD4+ T cells extracted from the bone marrow of patients with childhood acute T lymphoblastic leukemia. Loss-of-function and gain-of-function assays in vitro and in vivo revealed that membrane-localized and cytoplasm-localized lnc-INSR promoted Treg distribution and decreased the percentage of cytotoxic T lymphocytes, which induced tumor growth. Through direct binding with INSR, lnc-INSR blocked the INSR ubiquitination site, causing abnormal activation of INSR and the phosphatidylinositide 3-kinase\/AKT-signaling pathway. These results indicated that lnc-INSR might promote immune suppression by enhancing Treg-cell differentiation and serve as valuable therapeutic targets in the immunosuppressive tumor microenvironment.<\/jats:p>","DOI":"10.1038\/s41419-018-1078-8","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T12:06:57Z","timestamp":1539259617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Bone marrow infiltrated Lnc-INSR induced suppressive immune microenvironment in pediatric acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"9","author":[{"given":"Yaping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liucheng","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"1078_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-pathol-011811-132434","volume":"7","author":"AG Muntean","year":"2012","unstructured":"Muntean, A. G. & Hess, J. L. The pathogenesis of mixed-lineage leukemia. Annu. Rev. Pathol. 7, 283\u2013301 (2012).","journal-title":"Annu. Rev. Pathol."},{"key":"1078_CR2","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1200\/JCO.2016.71.8585","volume":"35","author":"J Bond","year":"2017","unstructured":"Bond, J. et al. Early response-based therapy stratification improves survival in adult early thymic precursor acute lymphoblastic leukemia: a group for research on adult acute lymphoblastic leukemia study. J. Clin. Oncol. 35, 2683\u20132691 (2017).","journal-title":"J. Clin. Oncol."},{"key":"1078_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ccell.2015.05.003","volume":"27","author":"D Passaro","year":"2015","unstructured":"Passaro, D. et al. CXCR4 is required for leukemia-initiating cell activity in t cell acute lymphoblastic leukemia. Cancer Cell 27, 769\u2013779 (2015).","journal-title":"Cancer Cell"},{"key":"1078_CR4","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.3900","volume":"49","author":"M Seki","year":"2017","unstructured":"Seki, M. et al. Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia. Nat. Genet. 49, 1274\u20131281 (2017).","journal-title":"Nat. Genet."},{"key":"1078_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrc.2016.63","volume":"16","author":"L Belver","year":"2016","unstructured":"Belver, L. & Ferrando, A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat. Rev. Cancer 16, 494\u2013507 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"1078_CR6","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/nm.4410","volume":"23","author":"AA Ferrando","year":"2017","unstructured":"Ferrando, A. A. & Lopez-Otin, C. Clonal evolution in leukemia. Nat. Med. 23, 1135\u20131145 (2017).","journal-title":"Nat. Med."},{"key":"1078_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2017.08.001","volume":"32","author":"D Passaro","year":"2017","unstructured":"Passaro, D. et al. Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell. 32, 324\u2013341 e326 (2017).","journal-title":"Cancer Cell."},{"key":"1078_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.ccr.2014.04.015","volume":"25","author":"CW Duan","year":"2014","unstructured":"Duan, C. W. et al. Leukemia propagating cells rebuild an evolving niche in response to therapy. Cancer Cell 25, 778\u2013793 (2014).","journal-title":"Cancer Cell"},{"key":"1078_CR9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nm.4103","volume":"22","author":"A Reinisch","year":"2016","unstructured":"Reinisch, A. et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat. Med. 22, 812\u2013821 (2016).","journal-title":"Nat. Med."},{"key":"1078_CR10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nri.2017.103","volume":"17","author":"CT Taylor","year":"2017","unstructured":"Taylor, C. T. & Colgan, S. P. Regulation of immunity and inflammation by hypoxia in immunological niches. Nat. Rev. Immunol. 17, 774\u2013785 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"1078_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature19801","volume":"538","author":"ED Hawkins","year":"2016","unstructured":"Hawkins, E. D. et al. T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments. Nature 538, 518\u2013522 (2016).","journal-title":"Nature"},{"key":"1078_CR12","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.cell.2017.11.013","volume":"171","author":"RM Kortlever","year":"2017","unstructured":"Kortlever, R. M. et al. Myc cooperates with ras by programming inflammation and immune suppression. Cell 171, 1301\u20131315 e1314 (2017).","journal-title":"Cell"},{"key":"1078_CR13","doi-asserted-by":"crossref","unstructured":"Barkal, A. A. et al. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy. Nat. Immunol. 19, 76\u201384 (2017).","DOI":"10.1038\/s41590-017-0004-z"},{"key":"1078_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nature22079","volume":"545","author":"AC Huang","year":"2017","unstructured":"Huang, A. C. et al. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 545, 60\u201365 (2017).","journal-title":"Nature"},{"key":"1078_CR15","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2017.07.024","volume":"170","author":"SC Wei","year":"2017","unstructured":"Wei, S. C. et al. Distinct cellular mechanisms underlie anti-CTLA-4 and Anti-PD-1 checkpoint blockade. Cell 170, 1120\u20131133 e1117 (2017).","journal-title":"Cell"},{"key":"1078_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature13848","volume":"517","author":"YH Huang","year":"2015","unstructured":"Huang, Y. H. et al. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature 517, 386\u2013390 (2015).","journal-title":"Nature"},{"key":"1078_CR17","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","volume":"114","author":"M Ahmadzadeh","year":"2009","unstructured":"Ahmadzadeh, M. et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114, 1537\u20131544 (2009).","journal-title":"Blood"},{"key":"1078_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","volume":"32","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Enhancing CD8(+) T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy. Cancer Cell. 32, 377\u2013391 e379 (2017).","journal-title":"Cancer Cell."},{"key":"1078_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nm.4278","volume":"23","author":"SQ Crome","year":"2017","unstructured":"Crome, S. Q. et al. A distinct innate lymphoid cell population regulates tumor-associated T cells. Nat. Med. 23, 368\u2013375 (2017).","journal-title":"Nat. Med."},{"key":"1078_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1126\/science.1251102","volume":"344","author":"E Tran","year":"2014","unstructured":"Tran, E. et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science 344, 641\u2013645 (2014).","journal-title":"Science"},{"key":"1078_CR21","doi-asserted-by":"publisher","first-page":"214ra169","DOI":"10.1126\/scitranslmed.3007247","volume":"5","author":"HS Robins","year":"2013","unstructured":"Robins, H. S. et al. Digital genomic quantification of tumor-infiltrating lymphocytes. Sci. Transl. Med. 5, 214ra169 (2013).","journal-title":"Sci. Transl. Med."},{"key":"1078_CR22","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1182\/blood-2015-08-662783","volume":"128","author":"I Azzaoui","year":"2016","unstructured":"Azzaoui, I. et al. T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells. Blood 128, 1081\u20131092 (2016).","journal-title":"Blood"},{"key":"1078_CR23","doi-asserted-by":"publisher","first-page":"e22654","DOI":"10.4161\/onci.22654","volume":"2","author":"AW Mailloux","year":"2013","unstructured":"Mailloux, A. W. & Epling-Burnette, P. K. Effector memory regulatory T-cell expansion marks a pivotal point of immune escape in myelodysplastic syndromes. Oncoimmunology 2, e22654 (2013).","journal-title":"Oncoimmunology"},{"key":"1078_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cell.2014.05.049","volume":"158","author":"T Trimarchi","year":"2014","unstructured":"Trimarchi, T. et al. Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell 158, 593\u2013606 (2014).","journal-title":"Cell"},{"key":"1078_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15129","volume":"8","author":"R Jiang","year":"2017","unstructured":"Jiang, R. et al. The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nat. Commun. 8, 15129 (2017).","journal-title":"Nat. Commun."},{"key":"1078_CR26","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","volume":"21","author":"LM Gjerdrum","year":"2007","unstructured":"Gjerdrum, L. M. et al. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia 21, 2512\u20132518 (2007).","journal-title":"Leukemia"},{"key":"1078_CR27","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/leu.2010.192","volume":"24","author":"AC Sprynski","year":"2010","unstructured":"Sprynski, A. C. et al. Insulin is a potent myeloma cell growth factor through insulin\/IGF-1 hybrid receptor activation. Leukemia 24, 1940\u20131950 (2010).","journal-title":"Leukemia"},{"key":"1078_CR28","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cell.2017.04.003","volume":"169","author":"R Tawo","year":"2017","unstructured":"Tawo, R. et al. The ubiquitin ligase CHIP integrates proteostasis and aging by regulation of insulin receptor turnover. Cell 169, 470\u2013482 e413 (2017).","journal-title":"Cell"},{"key":"1078_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7406","volume":"6","author":"MZ Cabail","year":"2015","unstructured":"Cabail, M. Z. et al. The insulin and IGF1 receptor kinase domains are functional dimers in the activated state. Nat. Commun. 6, 6406 (2015).","journal-title":"Nat. Commun."},{"key":"1078_CR30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0016-5085(03)00893-X","volume":"125","author":"L Khamzina","year":"2003","unstructured":"Khamzina, L., Gruppuso, P. A. & Wands, J. R. Insulin signaling through insulin receptor substrate 1 and 2 in normal liver development. Gastroenterology 125, 572\u2013585 (2003).","journal-title":"Gastroenterology"},{"key":"1078_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9283","volume":"6","author":"I Nemazanyy","year":"2015","unstructured":"Nemazanyy, I. et al. Class III PI3K regulates organismal glucose homeostasis by providing negative feedback on hepatic insulin signalling. Nat. Commun. 6, 8283 (2015).","journal-title":"Nat. Commun."},{"key":"1078_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12639","volume":"7","author":"A Nagarajan","year":"2016","unstructured":"Nagarajan, A. et al. MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels. Nat. Commun. 7, 12639 (2016).","journal-title":"Nat. Commun."},{"key":"1078_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fonc.2016.00162","volume":"6","author":"A Gopalakrishnapillai","year":"2016","unstructured":"Gopalakrishnapillai, A. et al. Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD\/SCID Mice. Front. Oncol. 6, 162 (2016).","journal-title":"Front. Oncol."},{"key":"1078_CR34","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","volume":"150","author":"SL Zhou","year":"2016","unstructured":"Zhou, S. L. et al. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib. Gastroenterology 150, 1646\u20131658 e1617 (2016).","journal-title":"Gastroenterology"},{"key":"1078_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nrgastro.2015.173","volume":"12","author":"J Prieto","year":"2015","unstructured":"Prieto, J., Melero, I. & Sangro, B. Immunological landscape and immunotherapy of hepatocellular carcinoma. Nat. Rev. Gastroenterol. & Hepatol. 12, 681\u2013700 (2015).","journal-title":"Nat. Rev. Gastroenterol. & Hepatol."},{"key":"1078_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ctrv.2017.11.008","volume":"63","author":"RL Ferris","year":"2017","unstructured":"Ferris, R. L. et al. Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation. Cancer Treat. Rev. 63, 48\u201360 (2017).","journal-title":"Cancer Treat. Rev."},{"key":"1078_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc.2017.86","volume":"17","author":"D Vijayan","year":"2017","unstructured":"Vijayan, D., Young, A., Teng, M. W. L. & Smyth, M. J. Targeting immunosuppressive adenosine in cancer. Nat. Rev. Cancer 17, 709\u2013724 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"1078_CR38","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.immuni.2016.01.013","volume":"44","author":"ME Turnis","year":"2016","unstructured":"Turnis, M. E. et al. Interleukin-35 Limits Anti-Tumor Immunity. Immunity 44, 316\u2013329 (2016).","journal-title":"Immunity"},{"key":"1078_CR39","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.2376","volume":"13","author":"S Chiba","year":"2012","unstructured":"Chiba, S. et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat. Immunol. 13, 832\u2013842 (2012).","journal-title":"Nat. Immunol."},{"key":"1078_CR40","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cell.2017.05.027","volume":"169","author":"T Merghoub","year":"2017","unstructured":"Merghoub, T. & Wolchok, J. D. Curbing Tregs\u2019 (Lack of) Enthusiasm. Cell 169, 981\u2013982 (2017).","journal-title":"Cell"},{"key":"1078_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14709","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Neuronal IFN-beta-induced PI3K\/Akt-FoxA1 signalling is essential for generation of FoxA1(+)Treg cells. Nat. Commun. 8, 14709 (2017).","journal-title":"Nat. Commun."},{"key":"1078_CR42","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1073\/pnas.0800928105","volume":"105","author":"S Sauer","year":"2008","unstructured":"Sauer, S. et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. . Natl. Acad. Sci. U. S. A. 105, 7797\u20137802 (2008).","journal-title":"Proc. . Natl. Acad. Sci. U. S. A."},{"key":"1078_CR43","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.4161\/cc.6444","volume":"7","author":"L Bruno","year":"2008","unstructured":"Bruno, L. & Merkenschlager, M. Directing T cell differentiation and function with small molecule inhibitors. Cell Cycle 7, 2296\u20132298 (2008).","journal-title":"Cell Cycle"},{"key":"1078_CR44","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1182\/blood-2011-11-364091","volume":"119","author":"EO Stenger","year":"2012","unstructured":"Stenger, E. O., Turnquist, H. R., Mapara, M. Y. & Thomson, A. W. Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity. Blood 119, 5088\u20135103 (2012).","journal-title":"Blood"},{"issue":"12","key":"1078_CR45","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1038\/leu.2017.116","volume":"31","author":"Y Lyu","year":"2017","unstructured":"Lyu Y., et al. Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways. Leukemia 31, 2543\u20132551 (2017).","journal-title":"Leukemia"},{"key":"1078_CR46","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1038\/leu.2014.126","volume":"28","author":"L Sehgal","year":"2014","unstructured":"Sehgal, L. et al. FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma. Leukemia 28, 2376\u20132387 (2014).","journal-title":"Leukemia"},{"key":"1078_CR47","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.4049\/jimmunol.1601011","volume":"198","author":"HJ Fischer","year":"2017","unstructured":"Fischer, H. J. et al. The insulin receptor plays a critical role in T cell function and adaptive immunity. J. Immunol. 198, 1910\u20131920 (2017).","journal-title":"J. Immunol."},{"key":"1078_CR48","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.4049\/jimmunol.1600230","volume":"199","author":"I Miyagawa","year":"2017","unstructured":"Miyagawa, I. et al. Induction of regulatory T cells and its regulation with insulin-like growth factor\/insulin-like growth factor binding protein-4 by human mesenchymal stem cells. J. Immunol. 199, 1616\u20131625 (2017).","journal-title":"J. Immunol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1078-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1078-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1078-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:23:36Z","timestamp":1671539016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1078-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["1078"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1078-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,11]]},"assertion":[{"value":"16 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1043"}}